联系方式:400-990-3999 / 邮箱:sales@xiyashiji.com
西亚试剂 —— 品质可靠,值得信赖
Prolactin Receptor (PRLR) regulates hepatic insulin sensitivity in mice via Signal Transducer and Activator of Transcription (STAT)5
Junjie Yu, Fei Xiao, Qian Zhang, Bin Liu, Yajie Guo, Ziquan Lv, Tingting Xia, Shanghai Chen, Kai Li, Ying Du and Feifan Guo
Insulin resistance is one of the major contributing factors in the development of metabolic diseases. The mechanisms responsible for insulin resistance, however, remain poorly understood. Although numerous functions of the prolactin receptor (PRLR) have been identified, a direct effect on insulin sensitivity has not been previously described. The aim of our current study is to investigate this possibility and elucidate underlying mechanisms. Here we show that insulin sensitivity is improved or impaired in mice injected with adenovirus that over-express or knock down PRLR expression, respectively. Similar observations were obtained in in vitro studies. In addition, we discovered that the Signal Transducer and Activator of Transcription (STAT)5 pathway is required for regulating insulin sensitivity by PRLR. Moreover, we observed that PRLR expression is decreased or increased under insulin-resistant (db/db) or insulin-sensitive (leucine deprivation) conditions, respectively, and found that altering PRLR expression significantly reverses insulin sensitivity under both conditions. Finally, we found that PRLR expression levels are increased under leucine deprivation via a General Control Nonderepressible (GCN)2/mammalian Target of Rapamycin (mTOR)/ribosomal protein S6 Kinase-1 (S6K1)-dependent pathway. These results demonstrate a novel function for hepatic PRLR in the regulation of insulin sensitivity and provide important insights concerning the nutritional regulation of PRLR expression.